Carbatrol

Company
Elan Pharmaceuticals

Approval Status
Approved September 1997

Treatment for
anticonvulsant and trigeminal neuralgia

Areas
Neurology & Nervous System

Carbatrol by Elan Corp. has been approved as a treatment for epileptic seizures and trigeminal neuralgia. Carbatrol is recommended for use twice daily as an extended release drug.

Carbatrol Drug Information

The Carbatrol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top